Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Fernandez-Real, J.M. (José Manuel) | - |
dc.creator | Menendez, J.A. (Javier A.) | - |
dc.creator | Frühbeck, G. (Gema) | - |
dc.creator | Moreno-Navarrete, J. (José) | - |
dc.creator | Martin, A. (Alejandro) | - |
dc.creator | Ricart, W. (Wifredo) | - |
dc.date.accessioned | 2012-10-09T11:55:08Z | - |
dc.date.available | 2012-10-09T11:55:08Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | Fernandez-Real JM, Menendez JA, Fruhbeck G, Moreno-Navarrete JM, Vazquez-Martin A, Ricart W. Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. Nutr Metab (Lond) 2010 Feb 25;7:14. | es_ES |
dc.identifier.issn | 1743-7075 | - |
dc.identifier.uri | https://hdl.handle.net/10171/23341 | - |
dc.description.abstract | HER2/neu is a member of the epidermal growth factor receptor family easily detectable in the serum of cancer patients. We aimed to evaluate circulating HER-2 concentrations in association with insulin resistance in healthy and obese subjects. METHODS: Insulin sensitivity (minimal model) and serum HER-2 concentrations were evaluated in a cross sectional study in men (cohort 1, n = 167) and longitudinally after weight loss in obese subjects (cohort 2, n = 30). RESULTS: Serum HER-2 concentrations were positively associated with BMI and waist circumference (both r = 0.18, p = 0.02), post-load glucose (r = 0.28, p = 0.001) and fasting triglycerides (r = 0.26, p = 0.001); and negatively associated with insulin sensitivity (r = -0.29, p = 0.002, n = 109). Subjects with type 2 diabetes showed significantly increased soluble serum HER-2 concentrations. In different multivariate regression models, fasting triglycerides emerged as the factor that independently contributed to 10-11% of serum HER-2 variance.Serum HER-2 concentrations correlated significantly with fasting triglycerides and insulin sensitivity index in subjects from cohort 2. Weight loss led to a significant decrease of serum HER-2 concentrations. The change in serum HER-2 concentrations were significantly associated with the change in percent body fat and fasting triglycerides in young (below the median age of the cohort) subjects. CONCLUSIONS: Serum HER-2 concentrations might be implicated in the pathophysiology of insulin resistance and associated comorbidities. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | BioMed Central | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Serum HER-2 | es_ES |
dc.subject | Insulin resistance | es_ES |
dc.title | Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-14.pdf | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.